← Back to Clinical Trials
Recruiting NCT06732700

NCT06732700 Effect of INIT on Cervical Proprioception in Patients With Forward Head Posture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06732700
Status Recruiting
Phase
Sponsor Riphah International University
Condition Forward Head Posture
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2024-04-18
Primary Completion 2024-12-22

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Integrated Neuromuscular Inhibition Technique and Posture Corrective Exercises.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2024-04-18 with a primary completion date of 2024-12-22.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to determine the effects of Integrated Neuromuscular Inhibition Technique on Cervical Proprioception in Patients with Forward Head Posture. A randomized control trial was conducted at Riphah International University, Gulberg Green Campus, Islamabad. The sample size was 42 calculated through G-Power. The participants were divided into two interventional groups each having 21 participants. The study duration was six months. Sampling technique applied was Non-probability Purposive sampling for recruitment. Only 18 to 40 years participants with CVA angle less than 50 degree were included in the study. Tools used in this study are Inclinometer, Mobile phone, Labtop, Kinovea Software, NPRS Scale, Laser Beam. Data was collected at Baseline, after 1st session at the end of 2nd week and 4th week. Data analyzed through SPSS version 23.

Eligibility Criteria

Inclusion Criteria: * Both Male and Female patients * CVA less than 50 degree * Age 18-40 years * Neck pain for more than 3 months * NPRS \> 3 * Decreased Cervical ROMs * Active trigger points in following muscles (Upper Trapezius, Sternocleidomastoid, Levator Scapulae) Exclusion Criteria: * History of cervical or facial trauma or surgery. * Congenital anomalies of spine such as scoliosis. * Systemic arthritis. * Any disorder of Central Nervous System. * Patients with cognitive deficit

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Lal Gul Khan, MScPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06732700 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Forward Head Posture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06732700 currently recruiting?

Yes, NCT06732700 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT06732700 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT06732700 clinical trial?

NCT06732700 is sponsored by Riphah International University. The principal investigator is Lal Gul Khan, MScPT at Riphah International University. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology